# Study of AT-527 in Healthy Subjects (R07496998)

> **NCT04711187** · PHASE1 · COMPLETED · sponsor: **Atea Pharmaceuticals, Inc.** · enrollment: 81 (actual)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** AT-527 Formulation 1
- **OTHER:** Placebo Comparator
- **DRUG:** AT-527 Formulation 2

## Key facts

- **NCT ID:** NCT04711187
- **Lead sponsor:** Atea Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-02
- **Primary completion:** 2021-09-15
- **Final completion:** 2021-09-15
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2022-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04711187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04711187, "Study of AT-527 in Healthy Subjects (R07496998)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04711187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*